Back
ALX Oncology Holdings Vs. Ligand Pharmaceuticals Industry Stock Comparison
Sell
42
ALXO
ALX Oncology Holdings
Last Price:
2.18
Seasonality Move:
40.85%
Buy
60
LGND
Ligand Pharmaceuticals
Last Price:
104.94
Seasonality Move:
1.98%
Sell
42
ALX Oncology Holdings (ALXO)
is a Sell
Is ALX Oncology Holdings a Buy, Sell or Hold?
- The current ALX Oncology Holdings [ALXO] share price is $2.18. The Score for ALXO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- ALXO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $105.01. The Score for LGND is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALXO Stock Price Chart
What is ALX Oncology Holdings's stock price today?
-
The ALX Oncology Holdings share price today is $2.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALXO is experiencing slight selling pressure.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $105.01
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing slight selling pressure.
ALXO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 34.55 | Sell |
| Chaikin Money Flow: | -151020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.08 - 2.48) | Sell |
| Bollinger Bands (100): | (2.39 - 12.11) | Sell |
LGND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 55.58 | Buy |
| Chaikin Money Flow: | -24402 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (102.37 - 105.49) | Buy |
| Bollinger Bands (100): | (81.28 - 103.6) | Buy |
ALXO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.17 | Buy |
| 20-day SMA: | 2.22 | Sell |
| 50-day SMA: | 3.66 | Sell |
| 200-day SMA: | 10.48 | Sell |
| 8-day EMA: | 2.17 | Buy |
| 20-day EMA: | 2.35 | Sell |
| 50-day EMA: | 3.73 | Sell |
| 200-day EMA: | 8.03 | Sell |
LGND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.79 | Buy |
| 20-day SMA: | 103.94 | Buy |
| 50-day SMA: | 102.69 | Buy |
| 200-day SMA: | 82.64 | Buy |
| 8-day EMA: | 104.03 | Buy |
| 20-day EMA: | 103.53 | Buy |
| 50-day EMA: | 100.36 | Buy |
| 200-day EMA: | 86.22 | Buy |
ALX Oncology Holdings Earnings Growth & ALXO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.24 per share.
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.72 per share, an increase next quarter of $0.29 per share, an increase this year of $0.04 per share, and an increase next year of $0.86 per share.
ALX Oncology Holdings Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ligand Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||